Skip to main content
SpringerLink
Log in

Genetics of hypogonadotropic hypogonadism

  • Introduction
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Determining the physiologic influences that modulate GnRH secretion, the prime initiator of reproductive function in the human, is fundamental not only to our understanding of the rare condition of congenital idiopathic hypogonadotropic hypogonadism (IHH), but also common disorders such as constitutional delay of puberty and hypothalamic amenorrhea. IHH is characterized by low levels of sex steroids and gonadotropins, normal findings on radiographic imaging of the hypothalamic-pituitary regions, and normal baseline and reserve testing of the remainder of the hypothalamic-pituitary axes. Failure of the normal pattern of episodic GnRH secretion results in delay of puberty and infertility. IHH is characterized by rich clinical and genetic heterogeneity, variable modes of inheritance, and association with other anomalies. To date, 4 genes have been identified as causes of IHH in the human; KAL [the gene for X-linked Kallmann syndrome (IHH and anosmia)], DAX1 [the gene for X-linked adrenal hypoplasia congenita (IHH and adrenal insufficiency)], GNRHR (the GnRH receptor), and PC1 (the gene for prohormone convertase 1, causing a syndrome of IHH and defects in prohormone processing). As these mutations account for less than 20% of all IHH cases, discovery of additional gene mutations will continue to advance our understanding of this intriguing syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Filicori M., Santoro N., Merriam G.R., Crowley W.F. Jr. Characterization of the physiologic pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J. Clin. Endocrinol. Metab. 1986, 62: 1136–1144.

    Article  CAS  PubMed  Google Scholar 

  2. Santoro N., Filicori M., Crowley W.F. Jr. Hypogonadotropic disorders in men and women: diagnosis and therapy with pulsatile gonadotropin-releasing hormone. Endocr. Rev. 1986, 7: 11–23.

    Article  CAS  PubMed  Google Scholar 

  3. Spratt D.I., Carr D.B., Merriam G.R., Scully R.E., Rao P.N., Crowley W.F. Jr. The spectrum of abnormal patterns of gonadotropinreleasing hormone secretion in men with idiopathic hypogonadotropic hypogonadism: clinical and laboratory correlations. J. Clin. Endocrinol. Metab. 1987, 64: 283–291.

    Article  CAS  PubMed  Google Scholar 

  4. Spratt D.I., O’Dea L.S.L., Schoenfeld D., Butler J., Rao P.N., Crowley W.F. Jr. Neuroendocrine-gonadal axis in men: frequent sampling of LH, FSH, and testosterone. Am. J. Physiol. Endocrinol. Metab. 1988, 254: E658–E666.

    CAS  Google Scholar 

  5. Hoffman A.R., Crowley W.F. Jr. Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone. N. Engl. J. Med. 1982, 307: 1237–1241.

    Article  CAS  PubMed  Google Scholar 

  6. Mason A.J., Hayflick J.S., Zoeller R.T., Young W.S. III, Phillips H.S., Nikolics K., Seeburg P.H. A deletion truncating the gonadotropin-releasing hormone gene is responsible for hypogonadism in the hpg mouse. Science 1986, 234: 1366–1371.

    Article  CAS  PubMed  Google Scholar 

  7. Weiss J., Adams E., Whitcomb R.W., Crowley W.F. Jr., Jameson J.L. Normal sequence of the gonadotropin-releasing hormone gene in patients with idiopathic hypogonadotropic hypogonadism. Biol. Reprod. 1991, 45: 743–747.

    Article  CAS  PubMed  Google Scholar 

  8. Weiss J., Crowley W.F. Jr., Jameson J.L. Normal structure of the gonadotropin-releasing hormone (GnRH) gene in patients with GnRH deficiency and idiopathic hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 1989, 69: 299–303.

    Article  CAS  PubMed  Google Scholar 

  9. Wray S., Grant P., Gainer H. Evidence that cells expressing luteinizing hormonereleasing hormone mRNA in the mouse are derived from progenitor cells in the olfactory placode. Proc. Natl. Acad. Sci. USA 1989, 86: 8132–8136.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Schwanzel-Fukuda M., Bick D., Pfaff D.W. Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Mol. Brain Res. 1989, 6: 311–326.

    Article  CAS  PubMed  Google Scholar 

  11. Franco B., Guioli S., Pragliola A., Incerti B., Bardoni B., Tonlorenzi R., Carrozzo R., Maestrini E., Pieretti M., Taillon-Miller P., Brown C.J., Willard H.F., Lawrence C., Persico M.G., Camerino G., Ballabio A. A gene deleted in Kallmann’s syndrome shares homology with neural cell adhesion and axonal pathfinding molecules. Nature 1991, 353: 529–536.

    Article  CAS  PubMed  Google Scholar 

  12. Legouis R., Hardelin J.P., Levilliers J., Claverie J.M., Compain S., Wunderle V., Millasseau P., Le Paslier D., Cohen D., Caterina D., Bougueleret L., Delemarrevar de Waal H.A., Lutfalla G., Weissenbach J., Petit C. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 1991, 67: 423–435.

    Article  CAS  PubMed  Google Scholar 

  13. Bick D., Franco B., Sherins R.J., Heye B., Pike L., Crawford J., Maddalena A., Incerti B., Pragliola A., Meitinger T., Ballabio A. Brief report: intragenic deletion of the KALIG-1 gene in Kallmann’s syndrome. N. Engl. J. Med. 1992, 326: 1752–1755.

    Article  CAS  PubMed  Google Scholar 

  14. Hardelin J.P., Levilliers J., del Castillo I., Cohen-Salmon M., Legouis R., Blanchard S., Compain S., Bouloux P., Kirk J., Moraine C., Chaussain J.-L., Weissenbach J., Petit C. X chromosome-linked Kallmann syndrome: stop mutations validate the candidate gene. Proc. Natl. Acad. Sci. USA. 1992, 89: 8190–8194.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Hardelin J.P., Levilliers J., Blanchard S., Carel J.-C., Leutenegger M., Pinard-Bertelletto J.-P., Bouloux P., Petit C. Heterogeneity in the mutations responsible for X chromosome-linked Kallmann syndrome. Hum. Mol. Genet. 1993, 2: 373–377.

    Article  CAS  PubMed  Google Scholar 

  16. Quinton R., Duke V.M., de Zoysa P.A., Platts A.D., Valentine A., Kendall B., Pickman S., Kirk J.M.W., Besser G.M., Jacobs H.S., Bouloux P.M.G. The neuroradiology of Kallmann’s syndrome: A genotypic and phenotypic analysis. J. Clin. Endocrinol. Metab. 1996, 81: 3010–3017.

    CAS  PubMed  Google Scholar 

  17. Georgopoulos N.A., Pralong F.P., Seidman C.E., Seidman J.G., Crowley W.F. Jr., Vallejo M. Genetic heterogeneity evidenced by low incidence of KAL-1 gene mutations in sporadic cases of gonadotropin-releasing hormone deficiency. J. Clin. Endocrinol. Metab. 1997, 82: 213–217.

    CAS  PubMed  Google Scholar 

  18. Rugarli E.I., Lutz B., Kuratani S.C., Wawersik S., Borsani G., Ballabio A., Eichele G. Expression pattern of the Kallmann syndrome gene in the olfactory system suggests a role in neuronal targeting. Nat. Genet. 1993, 4: 19–26.

    Article  CAS  PubMed  Google Scholar 

  19. Legouis R., Lievre C.A., Leibovici M., Lapointe F., Petit C. Expression of the KAL gene in multiple neuronal sites during chicken development. Proc. Natl. Acad. Sci. USA 1993, 90: 2461–2465.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Duke V.M., Winyard P.J.D., Thorogood P., Soothill P., Bouloux P-M.G., Woolf A.S. KAL, a gene mutated in Kallmann’s syndrome, is expressed in the first trimester of human development. Mol. Cell Endocrinol. 1995, 110: 73–79.

    Article  CAS  PubMed  Google Scholar 

  21. Lutz B., Kuratani S., Rugarli E.I., Wawersik S., Wong C., Bieber F.R., Ballabio A., Eichele G. Expression of the Kallmann syndrome gene in human fetal brain and in the manipulated chick embryo. Hum. Mol. Genet. 1994, 3: 1717–1723.

    Article  CAS  PubMed  Google Scholar 

  22. Hardelin J.P., Julliard A.K., Moniot B., Soussi-Yanicostas N., Verney C., Schwanzel-Fukuda M., Lievre C.A., Petit C. Anosmin-1 is a regionally restricted component of basement membranes and interstitial matrices during organogenesis: implications for the developmental anomalies of X chromosome-linked Kallmann syndrome. Dev. Dyn. 1999, 215: 26–44.

    Article  CAS  PubMed  Google Scholar 

  23. Burris T.P., Guo W., McCabe E.R. The gene responsible for adrenal hypoplasia congenita, DAX-1, encodes a nuclear hormone receptor that defines a new class with the superfamily. Rec. Prog. Horm. Res. 1996, 51: 241–259.

    CAS  PubMed  Google Scholar 

  24. Zanaria E., Muscatelli F., Bardoni B., Strom T.M., Guioli S., Guo W., Lalli E., Moser C., Walker A.P., McCabe E.R.B., Meitinger T., Monaco A.P., Sassone-Corsi P., Camerino G. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 1994, 372: 635–641.

    Article  CAS  PubMed  Google Scholar 

  25. Zhang Y.-H., Guo W., Wagner R.L., Huang B.-L., McCabe L., Vilain E., Burris T.P., Anyane-Yeboa K., Burghes A.H.M., Chitayat D., Chudley A.E., Genel M., Gertner J.M., Klingensmith G.J., Levine S.N., Nakamoto J., New M.I., Pagon R.A., Pappas J.G., Quiqley C.A., Rosenthal I.M., Baxter J.D., Fletterick R.J., Mclabe E.R.B. DAX1 mutations map to putative structural domains in a deduced three-dimensional model. Am. J. Hum. Genet. 1998, 62: 855–864.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Guo W., Burris T.P., McCabe E.R. Expression of DAX-1, the gene responsible for Xlinked adrenal hypoplasia congenita and hypogonadotropic hypogonadism, in the hypothalamic-pituitary-adrenal/gonadal axis. Biochem. Mol. Med. 1995, 56: 8–13.

    Article  CAS  PubMed  Google Scholar 

  27. Swain A., Zanaria E., Hacker A., Lovell-Badge R., Camerino G. Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function. Nat. Genet. 1996, 12: 404–409.

    Article  CAS  PubMed  Google Scholar 

  28. Ikeda Y., Shen W.H., Ingraham H.A., Parker K.L. Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Mol. Endocrinol. 1994, 8: 654–662.

    CAS  PubMed  Google Scholar 

  29. Crawford P.A., Dorn C., Sadovsky Y., Milbrandt J. Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1. Mol. Cell Biol. 1998, 18: 2949–2956.

    CAS  PubMed Central  PubMed  Google Scholar 

  30. Takahashi T., Shoji Y., Haraguchi N., Takahashi I., Takada G. Active hypothalamic-pituitary-gonadal axis in an infant with X-linked adrenal hypoplasia congenita. J. Pediatr. 1997, 130: 485–488.

    Article  CAS  PubMed  Google Scholar 

  31. Seminara S.B., Achermann J.C., Genel M., Jameson J.L., Crowley W.F. Jr. X-linked adrenal hypoplasia congenita: a mutation in DAX1 expands the phenotypic spectrum in males and females. J. Clin. Endocrinol. Metab. 1999, 84: 4501–4509.

    CAS  PubMed  Google Scholar 

  32. Yu R.N., Ito M., Saunders T.L., Camper S.A., Jameson J.L. Role of Ahch in gonadal development and gametogenesis. Nat. Genet. 1998, 20: 353–357.

    Article  CAS  PubMed  Google Scholar 

  33. Merke D.P., Tajima T., Baron J., Cutler G.B. Jr. Hypogonadotropic hypogonadism in a female caused by an X-linked recessive mutation in the DAX1 gene. N. Engl. J. Med. 1999, 340: 1248–1252.

    Article  CAS  PubMed  Google Scholar 

  34. Waldstreicher J., Seminara S.B., Jameson J.L., Geyer A., Nachtigall L.B., Boepple P.A., Holmes L.B., Crowley W.F. Jr. The genetic and clinical heterogeneity of gonadotropinreleasing hormone deficiency in the human. J. Clin. Endocrinol. Metab. 1996, 81: 4388–4395.

    CAS  PubMed  Google Scholar 

  35. Whitcomb R.W., Crowley W.F. Jr. Clinical review 4: diagnosis and treatment of isolated gonadotropin-releasing hormone deficiency in men. J. Clin. Endocrinol. Metab. 1990, 70: 3–7.

    Article  CAS  PubMed  Google Scholar 

  36. Stojilkovic S.S., Reinhart J., Catt K.J. Gonadotropin-releasing hormone receptors: structure and signal transduction pathways. Endocr. Rev. 1994, 15: 462–99.

    Article  CAS  PubMed  Google Scholar 

  37. de Roux N., Young J., Misrahi M., Genet R., Chanson P., Schaison G., Milgrom E. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N. Engl. J. Med. 1997, 337: 1597–1602.

    Article  PubMed  Google Scholar 

  38. Layman L.C., Cohen D.P., Jin M., Xie J., Li Z., Reindollar R.H., Bolbolan S., Bick D.P., Sherins R.R., Duck L.W., Musgrove L.C., Sellers J.C., Neili J.D. Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism. Nat. Genet. 1998, 18: 14–15.

    Article  CAS  PubMed  Google Scholar 

  39. Caron P., Chauvin S., Christin-Maitre S., Bennet A., Lahlou N., Counis R., Bouchard P., Kottler M.L. Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration. Clin. Endocrinol. Metab. 1999, 84: 990–996.

    Article  CAS  Google Scholar 

  40. de Roux N., Young J., Brailly-Tabard S., Misrahi M., Milgrom E., Schaison G. The same molecular defects of the gonadotropin-releasing hormone receptor determine a variable degree of hypogonadism in affected kindred. J. Clin. Endocrinol. Metab. 1999, 84: 567–572.

    PubMed  Google Scholar 

  41. Seminara S.B., Beranova M., Oliveira L.M.B., Martin K.A., Crowley W.F. Jr., Hall J.E. Successful use of pulsatile gonadotropin-releasing hormone (GnRH) for ovulation induction and pregnancy in a patient with GnRH receptor mutations. J. Clin. Endocrinol. Metab. 2000, 85: 556–562.

    CAS  PubMed  Google Scholar 

  42. O’Rahilly S., Gray H., Humphreys P., Krook A., Polonsky K.S., White A., Gibson S., Taylor K., Carr C. Impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function. N. Engl. J. Med. 1995, 333: 1386–1390.

    Article  PubMed  Google Scholar 

  43. Jackson R.S., Creemers J.W.M., Ohagi S., Raffin-Sanson M-L., Sanders L., Montague C.T., Hutton J.C., O’Rahilly S. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat. Genet. 1997, 16: 303–306.

    Article  CAS  PubMed  Google Scholar 

  44. Fluck C., Deladoey J., Rutishauser K., Eble A., Marti U., Wu W., Mullis P.E. Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg-Cys at codon 120 (R120C). J. Clin. Endocrinol. Metab. 1998, 83: 3727–3734.

    CAS  PubMed  Google Scholar 

  45. Cogan J.D., Wu W., Phillips J.A. III, Arnhold I.J.P., Agapito A., Fofanova O.V., Osorio M.G.F., Bircan I., Moreno A., Mendonca B.B. The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J. Clin. Endocrinol. Metab. 1998, 83: 3346–3349.

    CAS  PubMed  Google Scholar 

  46. Deladoey J., Fluck C., Buyukgebiz A., Kuhlmann B.V., Eble A., Hindmarsh P.C., Wu W., Mullis P.E. “Hot spot” in the PROP1 gene responsible for combined pituitary hormone deficiency. J. Clin. Endocrinol. Metab. 1999, 84: 1645–1650.

    CAS  PubMed  Google Scholar 

  47. Rosenbloom A.L., Almonte A.S., Brown M.R., Fisher D.A., Baumbach L., Parks J.S. Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of the PROP1 gene. J. Clin. Endocrinol. Metab. 1999, 84: 50–57.

    CAS  PubMed  Google Scholar 

  48. Bray G.A., York D.A. Genetically transmitted obesity in rodents. Physiol. Rev. 1971, 51: 598–646.

    CAS  PubMed  Google Scholar 

  49. Chehab F.F., Lim M.E., Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat. Genet. 1996, 12: 318–320.

    Article  CAS  PubMed  Google Scholar 

  50. Montague C.T., Farooqi I.S., Whitehead J.P., Soos M.A., Rau H., Wareham N.J., Sewter C.P., Digby J.E., Mohammed S.N., Hurst J.A., Cheetham C.H., Earley A.R., Barnett A.H., Prins J.B., O’Rahilly S. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997, 387: 903–908.

    Article  CAS  PubMed  Google Scholar 

  51. Strobel A., Issad T., Camoin L., Ozata M., Strosberg A.D. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat. Genet. 1998, 18: 213–215.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Reproductive Endocrine Unit, Massachusetts General Hospital, Fruit Street, Boston, MA, 02114, USA

    S. B. Seminara, L. M. B. Oliveira, M. Beranova, F. J. Hayes & W. F. Crowley Jr.

Authors
  1. S. B. Seminara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. M. B. Oliveira
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Beranova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. J. Hayes
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. W. F. Crowley Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. B. Seminara.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seminara, S.B., Oliveira, L.M.B., Beranova, M. et al. Genetics of hypogonadotropic hypogonadism. J Endocrinol Invest 23, 560–565 (2000). https://doi.org/10.1007/BF03343776

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343776

Key-words

Search

Navigation